BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35429745)

  • 1. Berberine reduces hepatic ceramide levels to improve insulin resistance in HFD-fed mice by inhibiting HIF-2α.
    Xia QS; Wu F; Wu WB; Dong H; Huang ZY; Xu L; Lu FE; Gong J
    Biomed Pharmacother; 2022 Jun; 150():112955. PubMed ID: 35429745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New role for ceramide in hypoxia and insulin resistance.
    Xia QS; Lu FE; Wu F; Huang ZY; Dong H; Xu LJ; Gong J
    World J Gastroenterol; 2020 May; 26(18):2177-2186. PubMed ID: 32476784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
    Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
    J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.
    Xie C; Yagai T; Luo Y; Liang X; Chen T; Wang Q; Sun D; Zhao J; Ramakrishnan SK; Sun L; Jiang C; Xue X; Tian Y; Krausz KW; Patterson AD; Shah YM; Wu Y; Jiang C; Gonzalez FJ
    Nat Med; 2017 Nov; 23(11):1298-1308. PubMed ID: 29035368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte Hypoxia-Inducible Factor 2α Suppresses Atherosclerosis by Promoting Adipose Ceramide Catabolism.
    Zhang X; Zhang Y; Wang P; Zhang SY; Dong Y; Zeng G; Yan Y; Sun L; Wu Q; Liu H; Liu B; Kong W; Wang X; Jiang C
    Cell Metab; 2019 Nov; 30(5):937-951.e5. PubMed ID: 31668872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity.
    Choe SS; Shin KC; Ka S; Lee YK; Chun JS; Kim JB
    Diabetes; 2014 Oct; 63(10):3359-71. PubMed ID: 24947359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
    Taniguchi CM; Finger EC; Krieg AJ; Wu C; Diep AN; LaGory EL; Wei K; McGinnis LM; Yuan J; Kuo CJ; Giaccia AJ
    Nat Med; 2013 Oct; 19(10):1325-30. PubMed ID: 24037093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
    Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
    J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liver Hif-2α-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition.
    Wei K; Piecewicz SM; McGinnis LM; Taniguchi CM; Wiegand SJ; Anderson K; Chan CW; Mulligan KX; Kuo D; Yuan J; Vallon M; Morton L; Lefai E; Simon MC; Maher JJ; Mithieux G; Rajas F; Annes J; McGuinness OP; Thurston G; Giaccia AJ; Kuo CJ
    Nat Med; 2013 Oct; 19(10):1331-1337. PubMed ID: 24037094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
    Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
    Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HIF-2α/PPARα pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis.
    Wang H; Wang L; Li Y; Luo S; Ye J; Lu Z; Li X; Lu H
    Biomed Pharmacother; 2021 Aug; 140():111778. PubMed ID: 34062416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of HIF-2α PAS-B domain contributes to physiological responses.
    Feng Z; Zou X; Chen Y; Wang H; Duan Y; Bruick RK
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13240-13245. PubMed ID: 30523118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway.
    Liu D; Zhang Y; Liu Y; Hou L; Li S; Tian H; Zhao T
    Exp Clin Endocrinol Diabetes; 2018 Sep; 126(8):513-520. PubMed ID: 29365334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
    Riopel M; Moon JS; Bandyopadhyay GK; You S; Lam K; Liu X; Kisseleva T; Brenner D; Lee YS
    Mol Metab; 2020 Nov; 41():101039. PubMed ID: 32534258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
    Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
    FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis.
    Brunt JJ; Shi SY; Schroer SA; Sivasubramaniyam T; Cai EP; Woo M
    Islets; 2014; 6(5-6):e1006075. PubMed ID: 25833250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-Inducible Factor-2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin-6.
    Gao RY; Wang M; Liu Q; Feng D; Wen Y; Xia Y; Colgan SP; Eltzschig HK; Ju C
    Hepatology; 2020 Jun; 71(6):2105-2117. PubMed ID: 31529728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
    Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
    Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.